Published in J Neurosci on May 23, 2007
Salsalate in Patients Mild to Moderate Alzheimer's Disease (SAL-AD) | NCT03277573
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS. Front Mol Neurosci (2011) 1.47
Targeting protein kinases in central nervous system disorders. Nat Rev Drug Discov (2009) 1.45
Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease. Neurobiol Dis (2011) 1.04
Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo. ACS Chem Neurosci (2012) 0.96
Glycogen synthase kinase 3 inhibitors in the next horizon for Alzheimer's disease treatment. Int J Alzheimers Dis (2011) 0.94
Disease-modifying drugs in Alzheimer's disease. Drug Des Devel Ther (2013) 0.92
Modulation of microglial innate immunity in Alzheimer's disease by activation of peroxisome proliferator-activated receptor gamma. Curr Med Chem (2009) 0.90
Recent developments of protein kinase inhibitors as potential AD therapeutics. Front Cell Neurosci (2013) 0.89
Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease. ACS Chem Neurosci (2012) 0.89
Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists. PPAR Res (2008) 0.87
Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8. PLoS One (2010) 0.86
PPARγ agonists promote oligodendrocyte differentiation of neural stem cells by modulating stemness and differentiation genes. PLoS One (2012) 0.86
Histamine H3 receptor antagonists in relation to epilepsy and neurodegeneration: a systemic consideration of recent progress and perspectives. Br J Pharmacol (2012) 0.86
Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins. Chem Biol (2012) 0.86
Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS One (2011) 0.85
Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy. Exp Neurol (2016) 0.83
GSK-3β controls autophagy by modulating LKB1-AMPK pathway in prostate cancer cells. Prostate (2015) 0.82
Glycogen synthase kinase 3β (GSK3β) modulates antiviral activity of zinc-finger antiviral protein (ZAP). J Biol Chem (2012) 0.81
In vivo glutamate decline associated with kainic acid-induced status epilepticus. Brain Res (2009) 0.80
Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice. EPMA J (2010) 0.80
Pharmacological Treatment of Alzheimer's Disease: Is it Progressing Adequately? Open Neurol J (2009) 0.75
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Behavioral paradigms to evaluate PPAR modulation in animal models of brain injury. Methods Mol Biol (2013) 0.75
Evaluation of longitudinal ventricular function with tissue Doppler echocardiography in children treated with anthracyclines. J Am Soc Echocardiogr (2007) 1.64
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS. Front Mol Neurosci (2011) 1.47
Antiretroviral therapy in acute and recent HIV infection: a prospective multicenter stratified trial of intentionally interrupted treatment. AIDS (2009) 1.35
Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J Biol Chem (2005) 1.34
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359. J Acquir Immune Defic Syndr (2005) 1.33
Alzheimer's disease peptide beta-amyloid interacts with fibrinogen and induces its oligomerization. Proc Natl Acad Sci U S A (2010) 1.28
Manzamine B and E and ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and Alzheimer's diseases. J Nat Prod (2006) 1.25
Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: advances in the development of specific phosphodiesterase inhibitors. Med Res Rev (2005) 1.21
CCAAT/enhancer-binding protein beta plays a regulatory role in differentiation and apoptosis of neuroblastoma cells. J Biol Chem (2001) 1.12
Protein kinases CK1 and CK2 as new targets for neurodegenerative diseases. Med Res Rev (2010) 1.09
Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice. Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.08
The transcription factor early growth response factor-1 (EGR-1) promotes apoptosis of neuroblastoma cells. Biochem J (2003) 1.02
15-deoxy-Delta-12,14-prostaglandin J2 induces programmed cell death of breast cancer cells by a pleiotropic mechanism. Carcinogenesis (2004) 0.99
CCAAT/enhancer binding protein beta deficiency provides cerebral protection following excitotoxic injury. J Cell Sci (2008) 0.99
Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. Curr Pharm Des (2006) 0.99
Enhancement of BRCA1 gene expression by the peroxisome proliferator-activated receptor gamma in the MCF-7 breast cancer cell line. Oncogene (2003) 0.97
Peroxisome proliferator-activated receptor γ ligands regulate neural stem cell proliferation and differentiation in vitro and in vivo. Glia (2011) 0.97
Glycogen synthase kinase 3 inhibition promotes adult hippocampal neurogenesis in vitro and in vivo. ACS Chem Neurosci (2012) 0.96
Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3. J Immunol (2013) 0.93
Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP/PS1 mice. Biol Psychiatry (2012) 0.90
Exploring the binding sites of glycogen synthase kinase 3. Identification and characterization of allosteric modulation cavities. J Med Chem (2011) 0.89
Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010. BMC Public Health (2011) 0.86
Inhibition of glioblastoma growth by the thiadiazolidinone compound TDZD-8. PLoS One (2010) 0.86
Dual inhibitor of PDE7 and GSK-3-VP1.15 acts as antipsychotic and cognitive enhancer in C57BL/6J mice. Neuropharmacology (2012) 0.85
Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS One (2011) 0.85
Phosphodiesterase 7 inhibitor reduced cognitive impairment and pathological hallmarks in a mouse model of Alzheimer's disease. Neurobiol Aging (2013) 0.85
Crosstalk between phosphodiesterase 7 and glycogen synthase kinase-3: two relevant therapeutic targets for neurological disorders. ACS Chem Neurosci (2014) 0.85
A dual role for the dREAM/MMB complex in the regulation of differentiation-specific E2F/RB target genes. Mol Cell Biol (2012) 0.85
The use of beta-D-2,6-diaminopurine dioxolane with or without mycophenolate mofetil in drug-resistant HIV infection. AIDS (2007) 0.84
5-imino-1,2,4-thiadiazoles: first small molecules as substrate competitive inhibitors of glycogen synthase kinase 3. J Med Chem (2012) 0.84
Neuroprotective efficacy of quinazoline type phosphodiesterase 7 inhibitors in cellular cultures and experimental stroke model. Eur J Med Chem (2011) 0.83
The RCPCH care pathway for food allergy in children: an evidence and consensus based national approach. Arch Dis Child (2011) 0.83
The spot 14 protein inhibits growth and induces differentiation and cell death of human MCF-7 breast cancer cells. Biochem J (2005) 0.82
PDE 7 inhibitors: new potential drugs for the therapy of spinal cord injury. PLoS One (2011) 0.82
Role of C/EBPβ transcription factor in adult hippocampal neurogenesis. PLoS One (2011) 0.82
Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds. J Med Chem (2012) 0.82
Absence of sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicity. J Acquir Immune Defic Syndr (2004) 0.82
1-, 3- and 8-substituted-9-deazaxanthines as potent and selective antagonists at the human A2B adenosine receptor. Bioorg Med Chem (2008) 0.81
Trophic effects of insulin-like growth factor-I (IGF-I) in the inner ear. Hear Res (2004) 0.81
Factors associated to duration of hepatitis a outbreaks: implications for control. PLoS One (2012) 0.80
Hypothyroidism decreases the biogenesis in free mitochondria and neuronal oxygen consumption in the cerebral cortex of developing rats. Endocrinology (2009) 0.80
Protein kinase CK-1 inhibitors as new potential drugs for amyotrophic lateral sclerosis. J Med Chem (2014) 0.80
Differences in sentinel influenza confirmed incidence rates and clinical presentation of influenza virus: 2008-09 seasonal vs 2009-10 pandemic influenza. Hum Vaccin (2011) 0.79
Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. Parkinsonism Relat Disord (2013) 0.78
15-Deoxi-Delta(12,14)-prostaglandin J2 is a tubulin-binding agent that destabilizes microtubules and induces mitotic arrest. Biochem Pharmacol (2009) 0.78
Developmental hypothyroidism increases the expression of kainate receptors in the hippocampus and the sensitivity to kainic acid-induced seizures in the rat. Endocrinology (2010) 0.78
5-Imino-1,2-4-thiadiazoles and quinazolines derivatives as glycogen synthase kinase 3β (GSK-3β) and phosphodiesterase 7 (PDE7) inhibitors: determination of blood-brain barrier penetration and binding to human serum albumin. Eur J Pharm Sci (2012) 0.78
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors. Angew Chem Int Ed Engl (2014) 0.78
Modulation of cAMP-specific PDE without emetogenic activity: new sulfide-like PDE7 inhibitors. J Med Chem (2014) 0.77
The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury. J Neurochem (2012) 0.77
Anticonvulsant and neuroprotective effects of the novel calcium antagonist NP04634 on kainic acid-induced seizures in rats. J Neurosci Res (2009) 0.77
Implication of the endocannabinoid system in the locomotor hyperactivity associated with congenital hypothyroidism. Endocrinology (2008) 0.76
Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor. J Med Chem (2006) 0.75
A small chemical library of 2-aminoimidazole derivatives as BACE-1 inhibitors: Structure-based design, synthesis, and biological evaluation. Eur J Med Chem (2011) 0.75
Unraveling phosphodiesterase surfaces. Identification of phosphodiesterase 7 allosteric modulation cavities. Eur J Med Chem (2013) 0.75
Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques. Bioorg Med Chem Lett (2005) 0.75
Reactivity of aluminum cluster anions with ammonia: selective etching of Al11(-) and Al12(-). J Chem Phys (2009) 0.75
Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease. Mini Rev Med Chem (2002) 0.75
AMPA glutamate receptors and neuropathic pain. Mini Rev Med Chem (2003) 0.75
Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning. Mol Cell Endocrinol (2012) 0.75
Products of the addition of water molecules to Al3O3- clusters: structure, bonding, and electron binding energies in Al3O4H2-, Al3O5H4-, Al3O4H2, and Al3O5H4. J Chem Phys (2004) 0.75
Enhancing cAMP Levels as Strategy for the Treatment of Neuropsychiatric Disorders. Curr Top Med Chem (2016) 0.75
Enantioselective LC/MS method for the determination of an antimalarial agent Fenozan B07 in dog plasma. Chirality (2006) 0.75
Glycogen synthase kinase-3. Int J Alzheimers Dis (2011) 0.75
Thyroid hormone regulates Galphai1 gene expression in the rat cerebellar cortex during post-natal development. J Neurochem (2005) 0.75
Developing a competency-based Pan-European Accreditation Framework for Health Promotion. Health Educ Behav (2012) 0.75